W
A. D. Williams, Kanner, J., Grantz, K. L., Ouidir, M., Sheehy, S., Sherman, S., Robledo, C., and Mendola, P.,
“Air pollution exposure and risk of adverse obstetric and neonatal outcomes among women with type 1 diabetes.”,
Environ Res, vol. 197, p. 111152, 2021.
D. J. Williams, C Creech, B., Walter, E. B., Martin, J. M., Gerber, J. S., Newland, J. G., Howard, L., Hofto, M. E., Staat, M. A., Oler, R. E., Tuyishimire, B., Conrad, T. M., Lee, M. S., Ghazaryan, V., Pettigrew, M. M., Fowler, V. G., Chambers, H. F., Zaoutis, T. E., Evans, S., and W Huskins, C.,
“Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial”,
JAMA Pediatr, vol. 176, no. 3, pp. 253-261, 2022.
S. D. Williams, Stablein, D. M., Einhorn, L. H., Muggia, F. M., Weiss, R. B., Donohue, J. P., Paulson, D. F., Brunner, K. W., Jacobs, E. M., and Spaulding, J. T.,
“Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer.”,
N Engl J Med, vol. 317, no. 23, pp. 1433-8, 1987.
C. Williams, Weaver, L. K., Langford, D., Lindblad, A., and Wierzbicki, M. R.,
“Neurological Evaluations within the Brain Injury and Mechanisms of Action of Hyperbaric Oxygen (HBO2) for Persistent Post-Concussive Symptoms after Mild Traumatic Brain Injury (mTBI) Study (BIMA)”, in
Undersea and Hyperbaric Medical Society Annual Scientific Meeting; Military Health System Research Symposium, 2014.
A. D. Williams, Grantz, K. L., Zhang, C., Nobles, C., Sherman, S., and Mendola, P.,
“Ambient Volatile Organic Compounds and Racial/Ethnic Disparities in Gestational Diabetes Mellitus: Are Asian/Pacific Islander Women at Greater Risk?”,
Am J Epidemiol, vol. 188, no. 2, pp. 389-397, 2019.
T. Williams, Blumberg, D., Perdue, L., Woolard, N., and Moreno, O.,
“Incorporating Web-based Training Tools and Technology in Clinical Trials Training”, in
Society for Clinical Trials (SCT) 36th Annual Meeting (2015), Arlington, VA, 2015.
H. Wiley, Bailey, C., Cukras, C., Jaffe, G., Lee, R., Loken, E., Meyerle, C., Thompson, D., Wong, W., and Ferris, F.,
“A Randomized 36-Week Crossover Trial Comparing Ranibizumab and Bevacizumab for Diabetic Macular Edema”, in
2015 Annual Meeting of The Association for Research in Vision and Ophthalmology (ARVO), Denver, CO, 2015.
H. E. Wiley, Thompson, D. J. S., Bailey, C., Chew, E. Y., Cukras, C. A., Jaffe, G. J., Lee, R. W. J., Loken, E. K., Meyerle, C. B., Wong, W., and Ferris, F. L.,
“A Crossover Design for Comparative Efficacy: A 36-Week Randomized Trial of Bevacizumab and Ranibizumab for Diabetic Macular Edema.”,
Ophthalmology, vol. 123, no. 4, pp. 841-9, 2016.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., Allingham, R. R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., and Lee, R. Kand,
“Common Variants at 9p21 and 8q22 are Associated with Increased Susceptibility to Optic Nerve Degeneration in Glaucoma”,
PLoS Genet, vol. 8, p. e1002654, 2012.
J. L. Wiggs, Yaspan, B. L., Hauser, M. A., Kang, J. H., R Allingham, R., Olson, L. M., Abdrabou, W., Fan, B. J., Wang, D. Y., Brodeur, W., Budenz, D. L., Caprioli, J., Crenshaw, A., Crooks, K., Delbono, E., Doheny, K. F., Friedman, D. S., Gaasterland, D., Gaasterland, T., Laurie, C., Lee, R. K., Lichter, P. R., Loomis, S., Liu, Y., Medeiros, F. A., McCarty, C., Mirel, D., Moroi, S. E., Musch, D. C., Realini, A., Rozsa, F. W., Schuman, J. S., Scott, K., Singh, K., Stein, J. D., Trager, E. H., VanVeldhuisen, P., Vollrath, D., Wollstein, G., Yoneyama, S., Zhang, K., Weinreb, R. N., Ernst, J., Kellis, M., Masuda, T., Zack, D., Richards, J. E., Pericak-Vance, M., Pasquale, L. R., and Haines, J. L.,
“Common variants at 9p21 and 8q22 are associated with increased susceptibility to optic nerve degeneration in glaucoma.”,
PLoS Genet, vol. 8, no. 4, p. e1002654, 2012.
L. Wieczorek, Peachman, K., Adams, D. J., Barrows, B., Molnar, S., Schoen, J., Dawson, P., Bryant, C., Chenine, A. - L., Sanders-Buell, E., Srithanaviboonchai, K., Pathipvanich, P., Michael, N. L., Robb, M. L., Tovanabutra, S., Rao, M., and Polonis, V. R.,
“Evaluation of HIV-1 neutralizing and binding antibodies in maternal-infant transmission in Thailand.”,
Virology, vol. 548, pp. 152-159, 2020.
L. E. Widdice, Unger, E. R., Panicker, G., Hoagland, R., S Callahan, T., Jackson, L. A., Berry, A. A., Kotloff, K., Frey, S. E., Harrison, C. J., Pahud, B. A., Edwards, K. M., Mulligan, M. J., Sudman, J., and Bernstein, D. I.,
“Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals.”,
Vaccine, vol. 36, no. 6, pp. 881-889, 2018.
L. E. Widdice, Hoagland, R., S Callahan, T., Kahn, J. A., Harrison, C. J., Pahud, B. A., Frey, S. E., Berry, A. A., Kotloff, K. L., Edwards, K. M., Mulligan, M. J., Sudman, J., Nakamura, A., and Bernstein, D. I.,
“Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series.”,
Vaccine, vol. 36, no. 11, pp. 1491-1499, 2018.
S. Whittier, Au, A., Sarraf, D., Oden, N., VanVeldhuisen, P., Scott, I., Ip, M., Watson, S., Blodi, B., and Domalpally, A.,
“Reproducibility of Grading Superficial vs Deep Retinal Hemorrhage in the Study of COmparative Treatments for REtinal Vein Occlusion 2 (SCORE2)”, in
Association for Research in Vision and Ophthalmology Annual Meeting, 2021.
T. L. Whiteside, Griffin, D. L., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D.,
“Shipping of therapeutic somatic cell products.”,
Cytotherapy, vol. 13, no. 2, pp. 201-13, 2011.
T. Whiteside, Griffin, D., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D.,
“Shipping of Therapeutic Somatic Cell Products”,
Cytotherapy, vol. 13, pp. 201-213, 2011.
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A.,
“Discontinuation of ant cytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis”,
JAMA, vol. 282, pp. 1633-37, 1999.
S. M. Whitcup, Fortin, E., Lindblad, A. S., Griffiths, P., Metcalf, J. A., Robinson, M. R., Manischewitz, J., Baird, B., Perry, C., Kidd, I. M., Vrabec, T., Davey, R. T., Falloon, J., Walker, R. E., Kovacs, J. A., Lane, H. C., Nussenblatt, R. B., Smith, J., Masur, H., and Polis, M. A.,
“Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.”,
JAMA, vol. 282, no. 17, pp. 1633-7, 1999.
P. A. Wetzel, Lindblad, A. S., Raizada, H., James, N., Mulatya, C., Kannan, M. A., Villamar, Z., Gitchel, G. T., and Weaver, L. K.,
“Eye Tracking Results in Postconcussive Syndrome Versus Normative Participants.”,
Invest Ophthalmol Vis Sci, vol. 59, no. 10, pp. 4011-4019, 2018.
D. Weisdorf, Carter, S., Confer, D., Ferrara, J., and Horowitz, M.,
“Blood and marrow transplant clinical trials network (BMT CTN): addressing unanswered questions.”,
Biol Blood Marrow Transplant, vol. 13, no. 3, pp. 257-62; discussion 255-6, 2007.
D. Weisdorf, Carter, S., Confer, D., Ferrara, J., M, H., ,, and Network, M. Transplant,
“Blood and Marrow Transplant Clinical Trials Network (BMT CTN): Addressing Unanswered Questions”,
Biol Blood Marrow Transplant, vol. 13, pp. 257-262, 2007.
D. J. Weisdorf, Hurd, D., Carter, S., Howe, C., Jensen, L. A., Wagner, J., Stablein, D., Thompson, J., and Kernan, N. A.,
“Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: A grading algorithm versus blinded expert panel review”,
Biol Blood Marrow Transplant, vol. 9, pp. 512-8, 2003.
D. Weisdorf, Hurd, D., Howe, C., Carter, S. L., Jensen, L., Harvath, L., Wagner, J., Stablein, D., and Kernan, K.,
“Prospective Grading of Graft versus Host Disease (GVHD) After Unrelated Donor BMT: A Grading Algorithm versus Blinded Expert Panel Review”, 2002.
D. J. Weisdorf, Hurd, D., Carter, S., Howe, C., Jensen, L. Ann, Wagner, J., Stablein, D., Thompson, J., and Kernan, N. A.,
“Prospective grading of graft-versus-host disease after unrelated donor marrow transplantation: a grading algorithm versus blinded expert panel review.”,
Biol Blood Marrow Transplant, vol. 9, no. 8, pp. 512-8, 2003.
D. V. Weinberg, Wahle, A. E., Ip, M. S., Scott, I. U., VanVeldhuisen, P. C., and Blodi, B. A.,
“Score Study Report 12: Development of venous collaterals in the Score Study.”,
Retina, vol. 33, no. 2, pp. 287-95, 2013.
]